Ronald C Petersen Selected Research

Peptides (Polypeptides)

12/2017	Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease.
1/2010	Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.
4/2009	Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald C Petersen Research Topics

Disease

280	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 04/2002
161	Cognitive Dysfunction 05/2024 - 11/2002
131	Dementia (Dementias) 04/2024 - 07/2003
60	Atrophy 05/2024 - 06/2005
36	Frontotemporal Dementia (Semantic Dementia) 03/2024 - 10/2003
32	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 03/2024 - 06/2006
21	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 04/2007
14	Tauopathies 05/2024 - 10/2007
14	Amyloidosis 11/2023 - 01/2010
14	Hypertension (High Blood Pressure) 01/2023 - 01/2011
13	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2023 - 10/2008
12	Amyloid Plaque 02/2024 - 07/2008
11	Disease Progression 01/2023 - 07/2008
10	Lewy Body Disease (Lewy Body Dementia) 01/2023 - 10/2008
9	Parkinsonian Disorders (Parkinsonism) 01/2023 - 11/2006
9	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2023 - 06/2006
9	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2012
9	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 09/2008
7	Neoplasms (Cancer) 01/2023 - 01/2005
7	Stroke (Strokes) 01/2022 - 05/2009
7	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2021 - 05/2015
6	Proteostasis Deficiencies 04/2024 - 02/2013
6	Vascular Diseases (Vascular Disease) 03/2024 - 05/2011
6	Prodromal Symptoms 02/2024 - 01/2013
6	Corticobasal Degeneration 12/2020 - 10/2003
5	Inflammation (Inflammations) 03/2024 - 12/2012
5	Infarction (Infarctions) 01/2023 - 10/2011
5	Hippocampal Sclerosis 01/2023 - 01/2017
5	Cerebral Cortical Thinning 01/2023 - 01/2019
5	Type 2 Diabetes Mellitus (MODY) 01/2018 - 02/2004
4	Aphasia (Dysphasia) 01/2024 - 01/2020
4	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2022 - 06/2014
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 06/2022 - 06/2014
4	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2021 - 03/2014
3	Genetic Risk Score 02/2024 - 01/2022
3	Chronic Renal Insufficiency 10/2023 - 01/2022
3	Synucleinopathies 01/2023 - 04/2013
3	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 01/2018
3	Multiple Sclerosis 01/2020 - 07/2015
3	Chronic Disease (Chronic Diseases) 01/2019 - 05/2015
3	Memory Disorders (Memory Loss) 01/2019 - 01/2014
3	Meningioma (Meningiomas) 01/2019 - 12/2017
3	Obesity 01/2018 - 01/2015
2	limbic-predominant age-related TDP-43 encephalopathy 11/2023 - 01/2023
2	Obstructive Sleep Apnea 11/2023 - 01/2022
2	Apnea 11/2023 - 01/2020
2	Pathologic Processes 01/2023 - 01/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2014
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

171	Amyloid (Amyloid Fibrils)IBA 04/2024 - 02/2004
166	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2005
59	Apolipoproteins E (ApoE)IBA 02/2024 - 11/2002
41	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2007
37	ApolipoproteinsIBA 12/2022 - 11/2002
34	DNA-Binding Proteins (DNA Binding Protein)IBA 05/2024 - 09/2008
30	Amyloid beta-PeptidesIBA 10/2023 - 02/2004
28	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 11/2021 - 08/2010
23	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2024 - 01/2016
15	ProgranulinsIBA 03/2024 - 11/2006
15	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 02/2004
12	UbiquitinIBA 03/2024 - 06/2006
9	Apolipoprotein E4IBA 12/2019 - 10/2011
9	Protons (Proton)IBA 11/2017 - 05/2003
9	Vitamin E FDA LinkGeneric 09/2015 - 01/2005
8	Donepezil (Aricept)FDA LinkGeneric 05/2017 - 01/2005
7	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2020 - 01/2009
6	LipidsIBA 03/2024 - 01/2011
6	SynucleinsIBA 01/2023 - 02/2007
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 06/2009
5	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2011
5	N 30IBA 01/2018 - 01/2009
4	Protein Isoforms (Isoforms)IBA 04/2023 - 10/2007
4	IronIBA 01/2022 - 12/2017
4	CeramidesIBA 11/2020 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2008
3	Indicators and Reagents (Reagents)IBA 01/2023 - 02/2010
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2010
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2009
3	LigandsIBA 01/2021 - 11/2013
3	HemosiderinIBA 01/2021 - 10/2013
3	PrionsIBA 12/2018 - 04/2016
3	Peptides (Polypeptides)IBA 12/2017 - 04/2009
3	Inositol (Myoinositol)IBA 11/2017 - 07/2008
3	florbetapirIBA 09/2015 - 10/2012
3	N-acetylaspartate (N-acetyl aspartate)IBA 03/2015 - 07/2008
2	Cholinergic Antagonists (Anticholinergics)IBA 05/2024 - 01/2016
2	Glial Fibrillary Acidic ProteinIBA 02/2024 - 01/2022
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2023 - 01/2021
2	alpha-SynucleinIBA 01/2023 - 01/2017
2	Leucine (L-Leucine)FDA Link 10/2022 - 10/2016
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022 - 08/2012
2	IGF-I-IGFBP-3 complex FDA Link 01/2022 - 03/2014

Therapy/Procedure

25	Therapeutics 12/2023 - 01/2005
6	Secondary Prevention 09/2017 - 04/2006
4	General Anesthesia 10/2019 - 02/2016
3	Anesthesia 08/2020 - 11/2018
3	Activities of Daily Living (ADL) 01/2020 - 07/2009
3	Mediterranean Diet 01/2017 - 01/2010
2	Precision Medicine 03/2023 - 01/2022